KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other Accumulated Expenses (2016 - 2026)

Abbott Laboratories' Other Accumulated Expenses history spans 18 years, with the latest figure at $6.4 billion for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 13.91% to $6.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $6.4 billion, a 13.91% increase, with the full-year FY2025 number at $5.8 billion, up 13.01% from a year prior.
  • Other Accumulated Expenses hit $6.4 billion in Q1 2026 for Abbott Laboratories, up from $5.8 billion in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for ABT hit a ceiling of $6.4 billion in Q1 2026 and a floor of $5.1 billion in Q2 2024.
  • Historically, Other Accumulated Expenses has averaged $5.5 billion across 5 years, with a median of $5.5 billion in 2022.
  • Biggest five-year swings in Other Accumulated Expenses: decreased 9.34% in 2024 and later rose 13.91% in 2026.
  • Tracing ABT's Other Accumulated Expenses over 5 years: stood at $5.8 billion in 2022, then dropped by 7.24% to $5.4 billion in 2023, then fell by 5.15% to $5.1 billion in 2024, then increased by 13.01% to $5.8 billion in 2025, then rose by 9.76% to $6.4 billion in 2026.
  • Business Quant data shows Other Accumulated Expenses for ABT at $6.4 billion in Q1 2026, $5.8 billion in Q4 2025, and $5.9 billion in Q3 2025.